Can real world evidence (RWE) really transform healthcare?
This is a guest article and does not necessarily reflect the views and values of Impetus Digital . The original [...]
United States: Update: Use Of Real-World Evidence In FDA Approvals And Product Promotion – Arnold & Porter
Real-world evidence (RWE)-clinical evidence on the use and benefits or risks of a medical product derived from real-world data (RWD)-has [...]
Pharma firm Advanz fined after thyroid drug price hike of 6,000% | Pharmaceuticals industry
The UK’s competition watchdog has imposed fines of more than £100m on the pharmaceutical company Advanz and its former private [...]
95 Pharma-Backed Oncologists Support Woodcock for FDA Commissioner
Dr. Janet Woodcock has faced widespread criticism as news spread that she was being considered for Food and Drug Administration [...]
Understanding the Impact of COVID-19 on Pharma Market Trends and Costs
The COVID-19 pandemic is bringing about major changes to the healthcare and pharma industries. Managing Director of BioPharma Futures Mel [...]
Informa Pharma Intelligence Launches Citeline Connect Clinical Trial Recruitment Platform to Accelerate Enrollment Timelines
NEW YORK (PRWEB) August 02, 2021 Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, has launched [...]
Philip Morris Acquires Several Companies, Details Beyond Nicotine Project in Brand Overhaul
Philip Morris International Inc. recently acquired OtiTopic, Vectura, and Fertin Pharma A/S. The acquired companies offer pharmaceutical products for heart [...]
Here are 3 major policy areas that health industry groups are closely watching in $3.5T infrastructure bill
The Senate is getting into the nitty-gritty of what exactly will be included in a massive $3.5 trillion infrastructure package [...]
Big Pharma dropped a lot of cash for a favorable National Academy of Sciences report.
To several U.S. senators, it looked wasteful, even outrageous. Every year, taxpayers pay for at least $750 million worth of [...]
Genoskin Launches ISR Platform, the First Human Skin Ex Vivo Platform to Study Injection Site Reactions (ISR)
- New patent filed protecting Genoskin’s unique ISR platform®, enabling human testing of allergic or pseudo-allergic inflammatory reactions induced by [...]
BCG Market Access Roundtable Article Highlights Healthcare and Pharma Trends Including RWD, Digital Tools, and Healthcare Policy Changes
The Boston Consulting Group (BCG) Market Access Roundtable shared updates to its key trends first released half a decade ago. [...]
Budding epithelial morphogenesis driven by cell-matrix versus cell-cell adhesion: Cell
Single-cell RNA sequencing data has been deposited in GEO: GSE159780 . All other source data and raw data that support [...]
Effective patient-first approach in rare disease relies on true sales—not channel stocking
Channel stocking is a common practice in which pharmaceutical executives opt to sell a sizable unit amount of a drug [...]
Signs of Health ‘Equity’s’ Chilling Effect on Dissent
The national movement to eradicate what activists call systemic racism and white privilege from medicine and health care has few [...]
HealthVerity Highlights Identity Component of RWD IPGE Platform
The HealthVerity Identity, Privacy, Governance, and Exchange (IPGE) platform recognizes identity as an integral component of its real world data [...]
Big Pharma makes historic earnings by increasing drug prices during a pandemic
Pharmaceutical firms are unveiling their Q2 earnings right now, and America’s largest drug manufacturers are flexing their muscles. Drug giants [...]
Managed Entry Agreements Could Bring Affordability to Multibillion-Dollar Novel Gene Therapy Market
Cogentia’s Senior Analyst Mark Orchard discusses how managed entry agreements (MEAs) could become a major trend in improving access to [...]
Bristol Myers Squibb Senior VP Discusses Career Journey, Leadership Style, and Improving Access to Drugs Globally
Ester Banque, senior vice president and head of Intercontinental Commercial at Bristol Myers Squibb, discusses her career path and evolving [...]
ISMPP Welcomes Abstracts for 2022 European Meeting
The International Society for Medical Publication Professionals (ISMPP) will hold its 2022 European Meeting on January 25th and 26th in [...]
Aetion Updates FDA Decision Alerts Database Following FDA’s Accelerated Approval of Oncology Drug LUMAKRAS
LUMAKRAS (sotarasib) was received accelerated approval from the Food and Drug Administration (FDA). The use of real world evidence (RWE) [...]
New Article Details $93.3 Billion Annual Costs in Drug Utilization Management
An article published in Health Affairs details the multibillion-dollar costs associated with inflated drug utilization management. The estimated $93.3 billion [...]
Aetion Adds Rabies Drug to FDA Decision Alerts Library Following Pediatric RWE Study
The Food and Drug Administration’s Center for Biologics Evaluation and Research has issued approval for a supplemental Biologics License Application [...]
ICER President Discusses How Iffy Biogen Decision May Bring Down FDA’s Accelerated Approval Program
Steve Pearson of the Institute for Clinical and Economic Review (ICER) weighed in on how the Food and Drug Administration’s [...]
MMIT’s AIS Health Article Details Efficacy and Costs of Specialty Drugs
MMIT’s AIS Health recently published an article on specialty pharmacy. Employers are typically resistant to drugs commanding high price tags. [...]
Pfizer and BioNTech Raise Price of COVID-19 Vaccine as UK Orders Booster Shots, Pfizer’s 2021 Sales Hit $11.3 Billion
Pfizer and BioNTech announced a price increase for COVID-19 booster shots—from £18 to £22. The European Union and the United [...]